首页> 外文期刊>Cost Effectiveness Resource Allocation >Insomnia - treatment pathways, costs and quality of life
【24h】

Insomnia - treatment pathways, costs and quality of life

机译:失眠-治疗途径,费用和生活质量

获取原文
           

摘要

Background Insomnia is perhaps the most common sleep disorder in the general population, and is characterised by a range of complaints around difficulties in initiating and maintaining sleep, together with impaired waking function. There is little quantitative information on treatment pathways, costs and outcomes. The aims of this New Zealand study were to determine from which healthcare practitioners patients with insomnia sought treatment, treatment pathways followed, the net costs of treatment and the quality of life improvements obtained. Methods The study was retrospective and prevalence based, and was both cost effectiveness (CEA) and a cost utility (CUA) analysis. Micro costing techniques were used and a societal analytic perspective was adopted. A deterministic decision tree model was used to estimate base case values, and a stochastic version, with Monte Carlo simulation, was used to perform sensitivity analysis. A probability and cost were attached to each event which enabled the costs for the treatment pathways and average treatment cost to be calculated. The inputs to the model were prevalence, event probabilities, resource utilisations, and unit costs. Direct costs and QALYs gained were evaluated. Results The total net benefit of treating a person with insomnia was $482 (the total base case cost of $145 less health costs avoided of $628). When these results were applied to the total at-risk population in New Zealand additional treatment costs incurred were $6.6 million, costs avoided $28.4 million and net benefits were $21.8 million. The incremental net benefit when insomnia was "successfully" treated was $3,072 per QALY gained. Conclusions The study has brought to light a number of problems relating to the treatment of insomnia in New Zealand. There is both inadequate access to publicly funded treatment and insufficient publicly available information from which a consumer is able to make an informed decision on the treatment and provider options. This study suggests that successful treatment of insomnia leads to direct cost savings and improved quality of life.
机译:背景失眠症可能是普通人群中最常见的睡眠障碍,其特征是,围绕着难以启动和维持睡眠以及清醒功能受损的一系列抱怨。关于治疗途径,费用和结果的定量信息很少。这项新西兰研究的目的是确定失眠患者从哪些医疗保健医生那里寻求治疗,遵循的治疗途径,治疗的净成本以及所获得的生活质量得到改善。方法该研究是回顾性和流行性基础的,既是成本效益(CEA)分析,也是成本效用(CUA)分析。使用了微成本计算技术,并采用了社会分析的观点。确定性决策树模型用于估计基本案例值,而随机模型和蒙特卡罗模拟则用于执行敏感性分析。每个事件都附带有概率和成本,这使得可以计算出治疗途径的成本和平均治疗成本。该模型的输入是患病率,事件概率,资源利用和单位成本。评估了直接成本和获得的QALY。结果治疗失眠症患者的总净收益为482美元(基本病例总费用145美元减去避免的医疗费用628美元)。将这些结果应用于新西兰的高危人群时,产生的额外治疗费用为660万美元,避免的费用为2840万美元,净收益为2180万美元。 “成功”治疗失眠时,每增加QALY可获得的净收益增量为3,072美元。结论该研究揭示了新西兰与失眠症治疗相关的许多问题。既得不到公共资助的治疗方法,又没有足够的公共可用信息,消费者无法从中获得有关治疗方法和提供者选择的明智决定。这项研究表明,成功治疗失眠症可直接节省成本并改善生活质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号